• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除后单结节肝细胞癌的肝内复发:按节段分布分析

Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distribution.

作者信息

Kim Jin-Min, Lee Seung-Hyun, Shin Woo Young, Lee Keon-Young, Kim Jun Mee, Ahn Seung-Ik

机构信息

Department of Surgery, Inha University School of Medicine, Incheon, South Korea.

Department of Pathology, Inha University School of Medicine, Incheon, South Korea.

出版信息

ANZ J Surg. 2018 Dec;88(12):E840-E844. doi: 10.1111/ans.14824. Epub 2018 Sep 17.

DOI:10.1111/ans.14824
PMID:30225975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6586000/
Abstract

BACKGROUND

Intrahepatic recurrence is the major cause of management failure after surgical resection of hepatocellular carcinoma (HCC). In the present study, we analysed intrahepatic recurrence by HCC distribution using Couinaud's liver segments.

METHODS

Recurrence proximity levels were defined with respect to primary tumour locations from Level LR (locoregional) to Level IV. Initial and recurrent tumours were compared with segmental distribution of their locations, and recurrence proximity levels were compared with initial tumour locations and disease-free survival.

RESULTS

Eighty-five (58.2%) of 146 patients with single nodular HCC experienced intrahepatic recurrence after surgical resection with a mean disease-free survival of 20.8 ± 21.1 months. Segmental distributions of initial and recurrent tumour locations were not significantly different (P > 0.05), and both were similar to the normal segmental volume distribution except segments S5, S6 and S8. Recurrences in proximity levels LR to IV were 11.1%, 34.9%, 25.4%, 21.4%, and 7.1%, respectively, and this distribution agreed well with theoretical proximity level distribution (P > 0.05). Disease-free survivals for different recurrence levels were not different (P = 0.530).

CONCLUSION

Intrahepatic recurrences after surgical resection of single nodular HCC occurred evenly in the remnant liver, and the timing was independent of the proximity between initial and recurrent tumours. Prevention was found to be proportional to the amount of liver segments removed. Surgical plans should take this into consideration.

摘要

背景

肝内复发是肝细胞癌(HCC)手术切除后治疗失败的主要原因。在本研究中,我们利用Couinaud肝段分析了HCC分布的肝内复发情况。

方法

根据原发肿瘤位置从LR(局部区域)水平到IV级定义复发接近水平。将初始肿瘤和复发肿瘤与其位置的节段分布进行比较,并将复发接近水平与初始肿瘤位置和无病生存期进行比较。

结果

146例单结节HCC患者中有85例(58.2%)在手术切除后发生肝内复发,平均无病生存期为20.8±21.1个月。初始肿瘤和复发肿瘤位置的节段分布无显著差异(P>0.05),除S5、S6和S8节段外,两者均与正常节段体积分布相似。接近水平LR至IV的复发率分别为11.1%、34.9%、25.4%、21.4%和7.1%,该分布与理论接近水平分布吻合良好(P>0.05)。不同复发水平的无病生存期无差异(P=0.530)。

结论

单结节HCC手术切除后的肝内复发在残余肝脏中均匀发生,且时间与初始肿瘤和复发肿瘤之间的接近程度无关。发现预防措施与切除的肝段数量成正比。手术计划应考虑到这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/c33a6ac55a75/ANS-88-E840-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/9c9cf829edf2/ANS-88-E840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/c210c6badac7/ANS-88-E840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/c33a6ac55a75/ANS-88-E840-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/9c9cf829edf2/ANS-88-E840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/c210c6badac7/ANS-88-E840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/6586000/c33a6ac55a75/ANS-88-E840-g003.jpg

相似文献

1
Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distribution.手术切除后单结节肝细胞癌的肝内复发:按节段分布分析
ANZ J Surg. 2018 Dec;88(12):E840-E844. doi: 10.1111/ans.14824. Epub 2018 Sep 17.
2
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.肝细胞癌切除术后早期和晚期肝内复发的不同危险因素及预后
Cancer. 2000 Aug 1;89(3):500-7.
3
Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.
Arch Surg. 1994 Jul;129(7):738-42. doi: 10.1001/archsurg.1994.01420310070012.
4
Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience.日本复发性肝细胞癌的特征及我们的手术经验。
J Hepatobiliary Pancreat Surg. 2001;8(5):397-403. doi: 10.1007/s005340100000.
5
Repeated liver resection for recurrent hepatocellular carcinoma.多次肝切除术治疗复发性肝细胞癌。
J Gastroenterol Hepatol. 2011 Jul;26(7):1189-94. doi: 10.1111/j.1440-1746.2011.06721.x.
6
Repeat liver resection for hepatocellular carcinoma.肝细胞癌的重复肝切除术
J Am Coll Surg. 2001 Mar;192(3):339-44. doi: 10.1016/s1072-7515(00)00789-4.
7
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.肝细胞癌肝切除术后复发:危险因素、治疗及预后
Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1.
8
Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection.肝细胞癌根治性切除术后复发后生存的预后因素
Anticancer Res. 2019 Jun;39(6):3033-3038. doi: 10.21873/anticanres.13436.
9
Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy.通过联合切除和局部区域治疗积极管理肝细胞癌肝外和肝内复发的患者。
J Am Coll Surg. 2002 Sep;195(3):311-8. doi: 10.1016/s1072-7515(02)01226-7.
10
Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.肝细胞癌术后肝内弥漫性复发的预测因素
Hepatogastroenterology. 2003 Jul-Aug;50(52):1078-84.

引用本文的文献

1
Robotic Liver Resection for Hepatocellular Carcinoma: A Multicenter Case Series.肝细胞癌的机器人肝切除术:多中心病例系列
Cancers (Basel). 2025 Jan 27;17(3):415. doi: 10.3390/cancers17030415.
2
Radiofrequency Ablation Therapy versus Stereotactic Body Radiation Therapy for Naive Hepatocellular Carcinoma (≤5cm): A Retrospective Multi-Center Study.射频消融治疗与立体定向体部放疗治疗初治肝细胞癌(≤5cm):一项回顾性多中心研究
J Hepatocell Carcinoma. 2024 Nov 13;11:2199-2210. doi: 10.2147/JHC.S488138. eCollection 2024.
3
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.

本文引用的文献

1
A Meta-analysis comparing the effect of anatomical resection vs. non-anatomical resection on the long-term outcomes for patients undergoing hepatic resection for hepatocellular carcinoma.一项比较解剖性切除与非解剖性切除对肝细胞癌肝切除患者长期预后影响的荟萃分析。
HPB (Oxford). 2017 Oct;19(10):843-849. doi: 10.1016/j.hpb.2017.06.003. Epub 2017 Jul 21.
2
Wide versus narrow margins after partial hepatectomy for hepatocellular carcinoma: Balancing recurrence risk and liver function.肝细胞癌肝部分切除术后宽切缘与窄切缘:平衡复发风险与肝功能
Am J Surg. 2017 Aug;214(2):273-277. doi: 10.1016/j.amjsurg.2017.06.002. Epub 2017 Jun 8.
3
肝硬化肝脏中肝细胞癌的节段性分布
Diagnostics (Basel). 2022 Mar 29;12(4):834. doi: 10.3390/diagnostics12040834.
4
COCH predicts survival and adjuvant TACE response in patients with HCC.COCH可预测肝癌患者的生存率及辅助性经动脉化疗栓塞(TACE)反应。
Oncol Lett. 2021 Apr;21(4):275. doi: 10.3892/ol.2021.12536. Epub 2021 Feb 10.
Functional Region Annotation of Liver CT Image Based on Vascular Tree.
基于血管树的肝脏CT图像功能区域标注
Biomed Res Int. 2016;2016:5428737. doi: 10.1155/2016/5428737. Epub 2016 Nov 7.
4
Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.肝细胞癌治疗的手术及非手术方法进展
Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):234-56. doi: 10.1016/s1499-3872(16)60097-8.
5
Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma.肝细胞癌根治性肝切除术后肝内多发复发的预测因素
Anticancer Res. 2015 May;35(5):3061-6.
6
Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.肝细胞癌最初在米兰标准内根治性切除术后肝内复发的适当治疗策略:根据复发模式
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):933-40. doi: 10.1097/MEG.0000000000000383.
7
Analysis of Recurrence Patterns After Anatomical or Non-anatomical Resection for Hepatocellular Carcinoma.肝细胞癌解剖性或非解剖性切除术后复发模式分析
Ann Surg Oncol. 2015 Jul;22(7):2243-52. doi: 10.1245/s10434-014-4214-4. Epub 2014 Nov 6.
8
Prognostic factors for hepatocellular carcinoma recurrence.肝细胞癌复发的预后因素。
World J Gastroenterol. 2014 May 28;20(20):5935-50. doi: 10.3748/wjg.v20.i20.5935.
9
MRI of hepatocellular carcinoma: an update of current practices.磁共振成像在肝细胞癌诊断中的应用:现状更新。
Diagn Interv Radiol. 2014 May-Jun;20(3):209-21. doi: 10.5152/dir.2014.13370.
10
Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.确定复发性肝细胞癌的克隆起源以进行个性化治疗和疗效评估:肝外科的新策略。
J Am Coll Surg. 2013 Dec;217(6):1054-62. doi: 10.1016/j.jamcollsurg.2013.07.402.